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Abstract 
 
Iron oxide nanoparticles (IONPs) have received considerable attention owing to its various 
biomedical application, including magnetic resonance imaging contrast agent, cancer targeting, and 
drug delivery. For the in-vivo application, the IONPs are required to be highly stable and biocompatible. 
However, the IONPs initially synthesized in organic solvent have hydrophobic ligands and they are 
unstable and toxic in physiological conditions. Therefore, surface modification of the IONPs must be 
considered to change hydrophobic ligands into hydrophilic ligands for bio-application. After the surface 
modification, physical properties of the IONPs are modified such as size, shape, hydrophobicity, surface 
charge, and coating materials. Especially, the surface charge of the IONPs is one of the most important 
factors because it affects colloidal stability of the IONPs and interactions with biomolecule in 
physiological condition. In our study, we fabricated highly stable and non-toxic IONPs via surface 
modification and tested their biocompatibility and potential for bio-functionalization. To process the 
surface modification, we synthesized PEG-based three different charged ligands via reversible addition-
fragmentation chain transfer-mediated (RAFT) polymerization and conducted the toxicological 
evaluation in vitro and in vivo. All of the charged IONPs showed long-term colloidal stability during 
three months in aqueous solution without agglomeration and no significant cellular damage in the A549, 
Huh-7, and SH-SY5Y cells. The charged IONPs have no significant toxicity in balb/c mice. We further 
developed more stable multidentate catechol-based zwitterionic ligand (MCZ-ligand) compared to 
polyethylene glycol-based ligands via RAFT polymerization. The IONPs coated with MCZ-ligand 
showed superior colloidal stability in a wide ranges of pH and saline solution for 1 year and low 
nonspecific adsorption with bovine serum albumin proteins. Furthermore, we confirmed the potential 
for bio-functionalization of the MCZ-IONPs. Biomolecules, biotin and streptavidin were conjugated on 
the MCZ-IONPs via carbodiimide chemistry and the bio-functionalization was confirmed via strong 
interaction between biotin and streptavidin. Consequently, our charged IONPs and zwitterionic IONPs 
performed excellent colloidal stability and non-toxicity in physiological conditions. These results open 
a possibility for biomedical application of the IONPs. 
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I. Introduction 
 
1.1 Iron Oxide Nanoparticles and Basic Properties 
 
Nanomaterials are defined as materials with one, two, or three external dimensions ranging from 1 
to 100 nm-the nanoscale.1 The uniform nanomaterials show many attractive properties such as electrical, 
optical, magnetic, and chemical properties, which cannot be accomplished by their bulk counterparts.2 
Among nanomaterials, magnetic nanoparticles (MNPs) with unique superparamagnetism, 
biocompatibility, and good stability have been extensively studied in many biomedical fields such as 
drug delivery, hyperthermia, magnetic resonance imaging (MRI), catalysis, data storage, electronic 
communication, and environmental remediation etc.3 Superparamagnetic iron oxide nanoparticles 
(SPIONs) consist of iron oxide cores such as magnetite (Fe3O4), maghemite (γ-Fe2O3) and hematite (α-
Fe2O3). Both maghemite and magnetite are traditionally ferromagnetic in nature with saturation 
magnetization reaching to 92 emu g-1. However, they lose their permanent magnetism and become 
superparamagnetic when they are decreased in size to 30 nm or smaller.1 Iron oxide nanoparticles 
(IONPs) also have various unique properties such as high surface-to-volume ratio or size dependent 
magnetic properties, low toxicity and easy modification. With these properties, the IONPs can be 
applied for bio-medical fields. 
There are many methods to synthesize IONPs such as co-precipitation method, hydrothermal 
reactions, thermal decomposition, microemulsion method, sol-gel reactions, aerosol/vapor phase 
method, and electrochemical method etc.4 Among them, thermal decomposition method has unique 
advantages of good control of size and shapes, and high yield. However, synthesized IONPs has 
hydrophobic ligands like oleic acid during the thermal decomposition process. Therefore, surface 
modification of the oleic acid-coated IONPs (OAc-IONPs) with a hydrophilic ligand must be required 
for bio-application (Figure 1). 
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Figure 1. Surface modification of OAc-IONPs. 
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1.2 Surface Modification of IONPs 
 
Surface medication of IONP is a crucial process because of following reasons: (1) Maintenance of 
the unique properties; (2) Enhancement of colloidal stability of IONPs without aggregation; (3) 
Improvement of the surface activity of IONPs for functionalization with useful molecule; (4) 
Biocompatibility, non-toxicity in biological condition, and stealth function from immune system; (5) 
Long-term circulation in physiological conditions. Through the surface modification, IONPs can be 
facilitated for biomedical application. 
For the surface modification of IONPs, there are three main methods; encapsulation and ligand 
exchange. First, encapsulation needs amphiphilic polymer which has both hydrophobic parts and 
hydrophilic parts. IONPs capped with hydrophobic ligands are coated with the amphiphilic polymers 
again. The inserted hydrophobic parts of amphiphilic polymers can interact with the hydrophobic 
ligands on IONPs. The hydrophilic parts of amphiphilic polymers render the IONPs water-dispersible 
in aqueous solution. The functional group of amphiphilic polymers also allows IONPs to be bio-
conjugated.5 Second, ligand exchange is one of the main methods for simply making IONPs soluble in 
aqueous solution by substituting the hydrophobic ligands with hydrophilic materials.6-7 The ligands are 
composed of anchoring group, hydrophilic group, and functional group. Anchoring group should have 
strong affinity to surface of IONPs because the ligands competitively substitute the hydrophobic ligands. 
An incomplete exchange or irreversible adsorption of the ligand can cause low colloidal stability in 
aqueous solution or biological conditions. To solve this problem, bidentate or multidentate anchoring 
groups can be introduced because they have high binding affinity onto IONPs. Compared to monomeric 
ligands, multidentate ligands can improve the colloidal stability. 
There are biocompatible inorganic or organic materials used for surface modification of IONPs. The 
functionalized IONPs have been utilized in various bio-application fields such as biolabeling, 
bioseparation, and catalysis.5 First, a variety of inorganic materials have been studied including silica, 
metal, metal oxides, sulfides, and nonmetals to provide IONPs biocompatibility. Silica-coated IONPs 
were colloidally stable, photostable, and water-stable.8 Gold shells enabled easy modification by thiol-
containing ligands and its gold-coated IONPs were quite stable because of their inertness. Second, 
organic compounds offering functional groups such as carboxylate, amine, hydroxyl, and aldehyde 
groups are easily able to bio-functionalize IONPs. Biomolecules such as DNA, protein, antibody, 
enzyme, and other nano-biomolecules can be linked to IONPs by introducing the organic functional 
groups, In addition, organic materials can provide IONPs biocompatibility from monomer to macro 
molecules such as citrate, phosphate, liposomes, proteins, and polymers. Many polymers have been 
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studied for biocompatible IONPs. For example, there are natural polymers like dextran and chitosan, 
and synthetic polymer like polyethylene glycol(PEG), polyethylenimine, polyacrylic acids and so on. 
When introducing organic compounds, we have to consider following subjects of IONPs such as 
controlling of shape, surface structure, stability, biocompatibility, and magnetic properties of IONPs.  
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1.3 Bio-Application and Toxicity Studies of IONPs 
 
Bio-functionalization of IONPs is one of the most important topics for the bio-application. There are 
two main strategies for bio-functionalization; one is non-covalent strategies and the other is covalent 
strategies. Non-covalent strategies use physical interactions between IONPs and bio-molecules for 
instance ionic coupling, hydrophobic coupling, biotin-avidin system and so on. Although these non-
covalent strategies have an advantage of easy functionalization, the conjugation is unstable and 
reproducibility is very low. On the contrary, the covalent coupling can make the IONPs obtain more 
stable and stronger conjugation with bio-molecules such as antibodies, enzymes, oligonucleotides, 
carbohydrates, peptides, or surface receptors by introducing amine, aldehydes, and epoxides groups. 
There are representative covalent coupling strategies including EDC coupling reaction, maleimide 
coupling, and click-chemistry reaction.9 Among them, EDC coupling reaction is the most widely 
introduced method because of its advantages. For the EDC coupling, carbodiimide is used to activate 
the reaction between carboxylate and amine for forming amide bond, which can be applicable to 
numerous molecules. EDC coupling can be conducted in various organic or hydrophilic solution and it 
also can easily eliminate by-product via dialysis or gel-filtration after the reaction. Maleimide coupling 
generally uses thiol reactive maleimide group for a conjugation with primary amine and thiols and the 
reaction is often introduced in the gold nanoparticles because of the strong affinity between thiol and 
gold nanoparticles.10 Click-chemistry reaction is easy, fast, and bio-orthogonal reaction, which can be 
effectively applied both in vitro and in vivo with specific interaction. Cupper (I)-catalyzed azide-alkyne 
cycloaddition (CuAAC) is one of the classic methods in the Click-chemistry reaction by using cupper 
catalyst for forming 5-membered heteroatom ring from azide and alkyne where cupper can cause 
cytotoxicity. To lower the toxicity, strain-promoted azide-alkyne cycloaddition (SPAAC) was developed 
without cupper by introducing a strained difluorooctyne and the SPAAC successfully utilized to prove 
for azide in living systems.11-12 Through these bio-functionalization, the IONPs can be applied in various 
biomedical fields e.g., diagnostic, cancer targeting, drug delivery, imaging, MRI contrast agent, 
magnetic hyperthermia, immunoassay, tissue repair, and cell tracking. 
However, prior to application of IONPs in the bio-medical fields, the toxicity studies on surface 
modified IONPs must be conducted because surface modification directly have an influence on 
cell/tissue biodistribution and clearance/metabolization.13 Generally plain IONPs pose a low health 
hazard because Fe is a naturally occurring metal in the human body. As the body is adapted to 
metabolizing the particles into its elements, IONPs can be utilized in the body via subsequent metabolic 
processes.14 However, surface functionalized IONPs can result in very different cellular responses as 
mentioned above. There are various factors influencing the cytotoxicity, e.g., size, shape, surface charge, 
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hydrophobicity, surface porosity, and roughness. In cells, NP-cell interaction can influence cellular 
uptake and internalization, and further affect cell morphology, proliferation, cytoskeleton, 
differentiation, and survival.13 In vivo, IONPs injected via intravenously injection can be almost cleared 
from the systemic circulation by macrophages residing in the reticuloendothelial.15 After being taken 
up into the cells via receptor-mediated endocytosis, the IONPs can be metabolized in the lysosomal 
compartments16 and free iron can be circulated in the body naturally. Therefore, the small quantities of 
injected IONPs do not cause toxicity issues although high amounts can lead to a toxicity in body. Figure 
2 shows drainage route of nanoparticles through different organs according to their size property.  
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Figure 2. Drainage route of nanoparticles through different organs.17 
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II. Synthesis of Different Charged Iron Oxide Nanoparticles via RAFT 
Polymerization for In Vitro and In Vivo Toxicity Evaluation 
 
2.1. Introduction 
 
IONPs have promising potential in various biomedical fields such as MRI contrast agents, biosensors, 
hyperthermia, drug delivery, cancer targeting, transfection, cell tracking, and tissue repair because of 
their low toxicity, magnetic properties, and easy surface-modification.18-23 In order to apply the IONPs 
to the bio-application, the IONPs should have excellent colloidal stability, ability of functionalization 
with biomolecules, and non-toxicity in physiological condition.24  
Through the surface modification process, the IONPs can be stable and biocompatible in the 
biological environment and have a useful functional groups capable of binding to various 
biomolecules.25-27 However, in the surface modification process, surface physi-co-chemical properties 
of IONPs could be changed inevitably during the surface modification process such as hydrodynamic 
diameter (H.D), shape, porosity, and surface charge of IONPs. Among these properties, it is well known 
that the change of the surface charge significantly influences cytotoxicity because it directly has an 
effect on the interaction between the charged IONPs and biological components.28 
Many research groups have studied the effect of the charged IONPs based on cytotoxicity, 
genotoxicity, and neurotoxicity.29-33 However, there has been a limitation of colloidal stability and 
chemical structure of surface ligand on the charged IONPs. For example, the charged IONPs can induce 
nonspecific interaction with proteins, and the phenomenon promotes another interaction between the 
charged IONPs and cells. This protein corona increasing H.D of particles induces the precipitation of 
nanoparticles and consequently causes the toxicity from particle uptake, pharmacokinetics, and bio-
distribution.34-35 Furthermore, almost studies on the charged IONPs involve variable in toxicity 
evaluation because of the different chemical structures of the ligand. Rivet et al.36 demonstrated that the 
charged IONPs were synthesized by using aminosilane, dextran, and poly-(dimethylamine-co-
epichlorhydrin-co-ethylendiamine for the cortical neuron cytotoxicity and showed a correlation 
between metabolic activity and surface charge. However, the other properties except for surface charge 
decorated with varieties of amine, alcohol, and zwitterion ligands, can also have another unpredictable 
effect on cytotoxicity. Therefore, for an accurate evaluation of cytotoxicity based on the surface charge 
by itself, the material must have high colloidal stability in a biological condition and minimize other 
variables in structure. 
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In this dissertation, we designed three different charged IONPs for enhancing the colloidal stability 
and minimizing the other variable in structure by using reversible addition-fragmentation chain transfer-
mediated (RAFT) polymerization method to systematically evaluate the in vitro and in vivo toxicity. 
The RAFT polymerization method has the advantage of controlling the ratio of the constituent materials, 
the molecular weight of the polymer, and polydispersity to exhibit uniform surface characteristics as 
desired.37 We synthesized three different charged polymeric ligands via RAFT polymerization; negative 
ligand ((-) ligand) used carboxyl group, neutral ligand ((n) ligand) based PEG moiety, and positive 
ligand ((+) ligand) used amine group. They had the same backbone and low polydispersity index (PDI) 
values. Subsequently, we made the three different charged IONPs (negatively charged IONPs ((-) 
IONPs), neutral IONPs ((n) IONPs), and positively charged IONPs ((+) IONPs)) by ligand exchange to 
evenly coat the surface of IONPs. The colloidal stability of the charged IONPs lasted for three months 
in deionized water (DIW) without changing their initial characteristics. We further evaluated the 
cytotoxicity of three IONPs in three different human cell lines; human lung cancer cell, human liver 
cancer cell, and human neural cancer cell by investigating viability change (MTT assay) and 
morphological alteration on the cells (confocal microscopy). In addition, in vivo toxicity study was 
performed by hematological analysis and histological analysis in mice. Notably all of our synthesized 
IONPs with superior colloidal stability showed excellent biocompatibility in vivo and in vitro test. 
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2.2 Materials and Experimental Section 
 
2.2.1 Materials. Iron(III) chloride hexahydrate, oleic acid, Dimethyl sulfoxide, Polyethylene glycol 
methyl ether acrylate (average Mn 480), acrylic acid, and Thiazolyl blue tetrazolium bromide were 
purchased from Sigma Aldrich (Korea). Sodium oleate, N-[3-Dimethylamino)propyl]acrylamide, and 
2-(2-Aminoethoxy)ethanol were purchased from TCI. 2,2’-Azobisisobutyronitrile was purchased from 
Samchun. N-[2-(3,4-Dihydroxyphenyl)ethyl]-2-methylprop-2-enamide (DMA), and dibenzyl 
trithiocarbonate were synthesized as previous reported method.38-39 A549, Huh-7, and SH-SY5Y were 
purchased from ATCC. RPMI 1640, Dulbecco’s modified Eagle’s medium (DMEM), Penicillin-
Streptomycin, and Trypsin/EDTA were purchased from Lonza. Fetal bovine serum was purchased from 
Gibco. DPBS was purchased from Welgene. 
2.2.2 Synthesis of OAc-IONPs. OAc-IONPs which have high crystallinity and uniform size 
distribution were synthesized by previously described thermal decomposition method.40 Briefly, 1 
mmol of iron oleate complex and 0.73 mmol of oleic acid were dissolved in 1.5 g 1-octadecene. The 
mixture was heated up to 320°C for 1 h 30 min, and kept at the temperature for 30 min. The 
nanoparticles were cooled to room temperature, and precipitated using 50 mL acetone and ethanol 
mixed solvent by centrifugation to obtain purified nanoparticles. The size and morphologies of 
nanoparticles were observed by transmission electron microscopy (TEM).  
2.2.3 Synthesis of Different Charged Polymer Ligands. We synthesized different charged 
polymeric ligands by RAFT polymerization method using different functional group to provide 
different charge on IONPs.37 For synthesis of the (n) ligand, (-) ligand, and (+) ligand, we used PEG, 
acrylic acid and tertiary amine as functional group respectively. All of the polymers were equally 
composed of 20% of DMA and 60% of PEG groups, 20% of functional groups. All monomers (1 mmol) 
were mixed in 1 mL N,N-Dimethylformamide and dibenzyl trithiocarbonate (RAFT reagent, 50 μmol) 
and 2,2’-Azobisisobutyronitrile were added in 5 mL ampule. Freeze-pump-thaw cycles were repeated 
4 times, and the ampule was sealed under vacuo using a torch gas. The ampule was heated up to 70°C 
for overnight and after reaction, the excess residues were washed with ethyl ether by centrifugation with 
three times. Solvent was removed in vacuum oven to obtain the polymer products.  
2.2.4 Synthesis of Different Charged IONPs. Ligand exchange method were used to modify OAc-
IONPs with synthesized polymer ligands. We mixed OAc-IONPs (5 mg), each polymer (30 mg) and 2-
(2-Aminoethoxy)ethanol (100 mg) in CHCl3, and react for 12 h at 60°C. After reaction, the solution 
was precipitated using diethyl ether by centrifugation (3 min, 3000 rpm) and dissolved in DIW. To 
remove the excess reagent, we used a centrifugal filter (MWCO 50 k) and washed out three times.  
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2.2.5 Characterization. TEM images were observed on JEM-2100F (JEOL) which was operated at 
200 kV. Polymers were analyzed by 1H nuclear magnetic resonance (NMR) using AVANCE III HD 
(Bruker) instrument at 400 MHz using deuterated chloroform solution. Molecular weight and molecular 
weight distribution were analyzed by gel permeation chromatography (GPC) (Shimadzu, RI detector). 
H.D, size distribution, and zeta-potentials of the IONPs in DIW and cell culture media were determined 
by dynamic laser scattering (DLS) particles size analyzer Nano-ZS90 (Malvern). All measurements 
were performed in 400 μL disposable cuvette using a 4 mW He-Ne laser operating at a wavelength of 
633 nm at 25°C and the scattering angle was fixed at 90°. Zeta-potentials were measured to confirm 
surface charge of the IONPs. Samples were prepared in DIW or cell culture media by diluting.  
2.2.6 Cell Lines and Cell Culture. The used cell lines are A549, Huh-7, and SH-SY5Y. Each cell 
was cultured in different suitable media and A549 and Huh-7 were cultured in RPMI 1640, SH-SY5Y 
in DMEM supplemented with 10% fetal bovine serum, 100 IU/mL penicillin, and 100 µg/mL 
streptomycin at 37°C under 5% CO2 in humidified incubator. 
2.2.7 MTT Assay. Cell viability was measured using MTT assay. For the test, the cells were seeded 
into 96-well flat-bottom plates at a starting density of 1 x 104 cells per well (A549 and Huh-7), and 4 x 
104 (SH-SY5Y) cells per well. All cells were cultured for 24 h, the IONPs were treated in each well and 
incubated for 24 h. After that IONPs were washed by DPBS three times and 10 μL (5 mg/mL) of 
thiazolyl blue tetrazolium bromide solution was added to each of 96 wells for 3 h at 37°C CO2 incubator. 
Cells were lysed with 150 μL of dimethyl sulfoxide and absorbance was measured by microplate reader 
(GloMax®  Discover, Promega) at 560 nm wavelength. 
2.2.8 Animal. Balb/c mice (male, 6 weeks) were purchased from the Orient-Bio Co. (Seongnam, 
Korea) and the mice were adapted for 7 day under environmentally controlled animal room conditions 
of a temperature (23±3C), relative humidity (50±20%), and air ventilation of 10–20 times/h with a 
12/12 h light/dark cycle.  
2.2.9 Hematological and Histological Analysis. The mice were randomly grouped and the IONPs 
were treated by intravenous injection of 2 mg Fe/kg (low dose, n = 3) and 10 mg Fe/kg (high dose, n = 
3) for 24 h once to observe acute toxicity. 1X PBS was used as negative control. Blood was collected 
from the caudal vena cava and serum was obtained by centrifugation at 3,000 rpm for 10 min at room 
temperature. Blood urea nitrogen (BUN), creatinine (CREA), alanine aminotransaminase (ALT), 
alkaline phosphatase (ALP), aspartate aminotransaminase (AST), total bilirubin (TBIL) were measured 
using a Dry Chem-3000 autoanalyzer (FujiFilm, Tokyo, Japan). Histological toxicity was rated from 
level 0 to level 5 in six organ; liver, kidney, lung, heart, spleen, and brain. 
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2.3 Results and Discussion 
 
2.3.1 Synthesis and Characterization of OAc-IONPs and Different Charged Ligands. For the 
clinical application of IONPs such as MRI contrast agents, it is important to synthesize homogeneous 
IONPs because magnetic properties and surface properties depend on the size of the IONPs,27 so we 
synthesized monodisperse OAc-IONPs by using a thermal decomposition method which can effectively 
control the size, polydispersity, and shape of the NPs with large quantities.40 As shown in Figure 3a, 
the uniform distribution of OAc-IONPs was observed (about 11.6 ± 0.7 nm) by TEM. The H.D of OAc-
IONPs was characterized by DLS measurement confirming that the size of Oac-IONP was about 14.58 
nm and PDI value was 0.046 (Figure 3b). Uniformity and reproducibility of OAc-IONPs are 
indispensable requirements for approval of FDA and we successfully synthesized homogeneous OAc-
IONPs that have small size variation in six different batches. 
It is necessary to go through the surface modification step of the initial OAc-IONPs with hydrophilic 
ligand in order to apply them to the biomedical environment because the OAc-IONPs are dispersed 
only in the organic solvent such as hexane or chloroform. Therefore, we designed and synthesized the 
surface coating materials via RAFT polymerization method which have multidentate anchoring groups 
and hydrophilic groups to improve colloidal stability and hydrophilic property of the OAc-IONPs. The 
RAFT polymerization method has the following advantages: (1) Easy introduction of various functional 
groups based on the same backbone moiety just depending on the type of monomers used in the 
polymerization. (2) Control of the composition and molecular weight of polymers as desired. (3) 
Synthesis of polymers with narrow polydispersity. 
The synthesized ligands were composed of three groups: anchoring group, hydrophilic group, and 
functional group. Catechol-derived dopamine was used as an anchoring group, which could coordinate 
with the surface of IONPs. The functional group was used to give different charges. Carboxyl group 
(acrylic acid) was used as a negative charge and tertiary amine group (N-[3-(Dimethylamino)propyl] 
acrylamide)) was used as the positive charge. As a hydrophilic group, a substance containing PEG was 
used because the hydrophilic property of PEG improves the dispersibility of IONPs in aqueous solution. 
In general, PEG has several advantages such as increasing biocompatibility, reducing immunogenicity, 
and providing stability between particles via steric repulsion.41 It also reduces the adsorption of various 
plasma proteins42 and enables the circulation in the body for a long time in vivo. Therefore, PEG is one 
of the ideal coating materials.43-44 Prior to synthesis of charged ligands, we tested whether RAFT 
polymerization system could work successfully in the synthesis of (n) ligand. Molecular weight of 
polymer was well controlled by using RAFT agent. In case of using the RAFT agent, the PDI value was 
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1.19 although the PDI was 1.79 without RAFT agent (Figure 4a). Also, degree of polymerization (DP) 
of the (n) ligand was increased as the [Monomer]:[RAFT] ratio increase, although there was a difference 
between the theoretical [Monomer]:[RAFT] ratio and the measured degree of polymerization (DP) of 
the (n) ligand analyzed by GPC (in Figure 4b). We presupposed that this result could be caused by 
catechol group which could be used as radical scavenger. Also, we confirmed that well controllable 
polymerization of (n) ligand. It was possible to control of the monomer ratio in polymer by RAFT 
polymerization method. [DMA]:[PEG] ratio in polymer were well controlled as desired. In Figure 5, 
calculated ratio of DMA to PEG in (n) ligand measured by 1H NMR was corresponded approximately 
to theoretical ratio as we desired. Based on these results, three charged ligand were synthesized. We 
designed the final polymer composition with 20% of anchoring groups (DMA), 50% of hydrophilic 
groups (PEG moieties), and 30% of neutral groups, negatively or positively charged functional groups 
for charged IONPs respectively (Figure 6a). The reason of the polymer design was that dispersity of 
the nanoparticles in the cell culture media was remarkably decreased in the case of the ligand composed 
of 20% of the anchoring group and 80% of the functional group without the PEG part although the 
nanoparticles were well dispersed in the aqueous solution (Figure 7). It was confirmed that each 
monomer was polymerized at a desired ratio by the 1H NMR spectra as shown in Figure 6b. Each 
proton peak of DMA, PEG, and tertiary amine was observed at 6.5~6.8 ppm, 3.64 ppm, and 2.25 ppm 
by 1H NMR spectroscopy, respectively. The (n) ligand was functionalized with 18% of the anchoring 
group and 82% of the hydrophilic group. In the case of the (+) ligand, the anchoring group was 18%, 
the hydrophilic group was 49% and the quaternary amine functional group was 31%. In the case of the 
(-) ligand, the ratio of anchoring and hydrophilic groups were identical to the (+) ligand so we expect 
the monomer ratio of (-) ligand. Molecular weight of (-) ligand, (n) ligand, (+) ligand was 6741 (PDI = 
1.28), 9122 (PDI = 1.29), 3144 (PDI = 1.25) respectively, and the PDI values of all the ligands were 
low (PDI < 1.3).  
 
  
22 
 
 
 
Figure 3. Synthesis of OAc-IONPs. (a) TEM image and (b) H.D of OAc-IONPs of dispersed in hexane 
measured by DLS. 
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Figure 4. RAFT polymerization of (n) ligand. (a) Result of GPC analysis of (n) ligand in THF, showing 
narrow PDI with a [Monomer]:[RAFT] ratio of 20:1 and [AIBN]:[RAFT] ratio of 1:1 (red line), and 
poor PDI without RAFT agent (black line). (b) Controllable polymer DP as a [Monomer] to [RAFT] 
ratio. 
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Figure 5. Control of monomer ratio in polymers. Result of 1H-NMR analysis. 
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Figure 6. RAFT polymerization reaction for synthesis of different charged polymer ligands. (a) Scheme 
of ligand synthesis, and (b) 1H-NMR analysis of charged ligands in CDCl3. 
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Figure 7. Stability test of 80% positively charged IONPs. (a) H.D of 80% positively charged IONP 
dispersed in DIW and RPMI 1640 media. (b) Camera image of the IONPs dispersed in DIW, and (c) 
agglomerated in RPMI 1640 media. 
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2.3.2 Ligand Exchange of IONPs for Dispersing in the Aqueous Solution. After the synthesis of 
ligands, we did a ligand exchange to convert the hydrophobic material initially synthesized in the 
organic solvent into a water-dispersible hydrophilic material as shown in Figure 8a. The ligand 
exchange has the advantage of simply compacting ligands without significantly increasing of H.D. It is 
very important to coat the surface uniformly and compactly for the accurate analysis of surface 
characteristics and reproducible synthesis of IONPs. We could also obtain a consistent toxicity 
evaluation value under the proposed ligand exchange method. As shown in Figure 8b, the uniform 
distribution of OAc-IONPs (about 11.6 ± 0.7 nm) and surface-modified three IONPs were observed by 
TEM. The H.D of OAc-IONPs was also uniformed about 14.58 nm and PDI value was 0.046. Also, 
synthesized compact and uniform IONPs showed no big change of the H.D between OAc-IONPs and 
three charged IONPs (Figure 8c). The PDI values of them were low (0.25-0.3). The surface charge of 
each charged IONPs was measured by zeta-potential as shown in Figure 8d. The surface charge of (-) 
IONPs, (n) IONPs, and (+) IONPs was -39 mV, -0.6 mV, and +32 mV, respectively. As a result, three 
different charged IONPs were successfully synthesized. 
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Figure 8. Characterization of IONPs after the ligand exchange. (a) Schematic illustration of ligand 
exchange of OAc-IONPs with charged ligands, (b) TEM images of OAc-IONPs dispersed in hexane 
and three charged IONPs dispersed in DIW. (c) H.D of OAc-IONPs and the three charged IONPs, and 
(d) zeta-potential of three charge IONPs. 
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2.3.3 Stability of IONP in DIW and Cell Culture Media. It is important to provide the stable 
nanoparticles with the properties of the material maintained in an aqueous condition. Although the 
synthesized nanoparticles have initial colloidal stability, they may become unstable due to the changes 
in physical properties depending on the storage period and the storage method, which affects the toxicity 
of IONPs. Therefore, we tested the stability of IONPs by storing IONPs in DIW at 4°C refrigerator for 
three months after sealing them with a parafilm and wrapping them in the foil and by measuring DLS 
and zeta-potential value of IONPs. In Figure 9a, the H.D of the (-) IONPs and the (n) IONPs shows a 
very subtle increase in the DIW. The change of H.D of the (-) IONPs and (n) IONPs was ± 5.36 nm and 
± 4.98 nm over the three months, respectively. Moreover, the (+) IONP remained constant at ± 1.57 nm 
with almost no change in size. In Figure 9b, the zeta-potential value of (-) IONPs, (n) IONPs, and (+) 
IONPs was ± 6.24 mV, ± 2.31 mV, and ± 4.77 mV respectively. Notably all the synthesized IONPs with 
polymer ligands show high stability in their size and surface charge. 
We further studied the stability of IONPs in the cell culture media where there are a lot of factors 
affecting the physi-co-chemical properties of nanomaterials such as proteins, salts, and various pH 
conditions. We used RPMI 1640 media and DMEM media to find out the stability of the IONPs for two 
days and then analyzed the H.D by DLS as shown in Figure 9c and Figure 9d. In general, charged 
substances tend to aggregate or form protein corona in media.45 However, all of our charged IONPs 
showed no change in their size for two days in both RPMI 1640 and DMEM media. This means that all 
of the differently charged IONPs were stable enough to conduct in vitro test to fulfill the requirements 
of the same condition as above. The origin of the high stability of IONPs is from robust binding affinity 
between catechol and iron ion owing to multi-anchor group. In addition, introducing the PEG moiety 
and adequate charged group to surface of IONPs also endow optimized NP stability via combination of 
steric hindrance and charge-charge repulsion. Therefore, we could make an accurate toxic evaluation 
system with three kinds of charged IONPs with minimizing the variable factors derived from material 
property which would be addressed in the next section.   
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Figure 9. Colloidal stability of three charged IONPs in DIW for three months and cell culture media 
for two days. (a) H.D and (b) zeta-potential of three charged IONPs in water for three months. H.D of 
three charged IONPs (c) in RPMI1640 media and (d) in DMEM media for two days. 
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2.3.4 Cell Viability and Morphological alteration on the Cells. To determine if the surface charge 
of IONPs influences the cytotoxicity of IONPs, we conducted an MTT assay in the three human cell 
lines.46 A549 (human lung cancer cell), Huh-7 (human liver cancer cell), and SH-SY5Y (human neural 
cancer cell) were used as the cell lines to confirm the cytotoxicity of different three target organs such 
as lung, liver, and nerve against external substances.47 After each cell was treated with various 
concentration (0, 2, 8, 31, 125, and 500 µg Fe/mL) of each differently charged IONPs for 24 h, the 
adsorption of formazan was measured at 560 nm as shown in Figure 10. In each cell line, all of the 
IONPs showed the similar tendency of cell viability. The viability showed a slightly decrease depending 
on concentration of IONPs. It is generally known that positively charged nanoparticles are more uptaken 
because of electronic interaction with the cell membrane, which consequently leads to a serious toxicity. 
However, in our study, all of the three IONPs showed low toxicity even if it was treated with 500 µg 
Fe/mL.  
To verify the effect of IONPs on cell morphology, we confirmed cell morphology with differently 
charged IONPs by microscopy in each cells at two concentration of 10 µg Fe /mL and 100 µg Fe/mL 
as shown in Figure 11. It was confirmed that morphology alteration in A549, Huh-7, and SH-SY5Y 
cells was not observed up to high concentration compared to the control group. Based on the MTT assay 
and observation of cell morphology, we could conclude that there was no cytotoxicity in our charged 
IONPs. 
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Figure 10. Effect of the three charged IONPs on the viability of three different cells; A549, Huh-7, 
SH-SY5Y cells. All cells were exposed for 24 h to increasing concentrations upon 500 µg Fe/mL. Cell 
viability was analyzed by MTT assay. 
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Figure 11. Cell morphological alteration in A549, Huh-7, and SHSY-5Y after treatment of three IONPs 
with 10 and 100 μg Fe/mL by microscopy. 
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2.3.5 Hematological and Histological Toxicity in Mice. To observe the in vivo toxicity of three 
different charged IONPs in mice, we conducted hematological and histological analysis. The three 
differently charged IONPs were treated in mice at 2 µg Fe/g and 10 µg Fe/g for 24 h via intravenous 
injection respectively. In the hematological analysis, we tested following parameter: BUN and CREA 
associated with the kidney function and ALT, ALP, AST, and TBIL associated with the liver function. 
All the three IONPs showed no significant changes in all blood parameters compared to negative control 
(Figure 12).  
A histological examination was also performed and six organs were observed; liver, kidney, lung, 
heart, spleen and brain which were rated from level 0 to level 5. The (-) IONPs and (+) IONPs showed 
weak toxicity equivalent to level 1 in kidney and heart, respectively. Although the (n) IONPs showed 
toxicity of level 1 and 2 depend on concentration in both liver and kidney, it was not a serious toxicity 
such as necrosis. The (n) IONPs showed higher toxicity level than (-) IONPs and (+) IONPs because 
the (n) IONPs has more PEG moiety than other two IONPs. These results are consistent with reported 
studies to be related side effects of the PEGylation.48 However, all the synthesized IONPs showed no 
significant toxicity in vivo test such as necrosis or accurate toxicity (Figure 13). These results indicate 
that charged IONPs can apply to various biomedical field as biocompatible materials by controlling the 
surface ligand and depending on usage. 
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Figure 12. Hematological analysis of balb/c mice following injection of three charged IONPs. The 
graphs show the concentration of BUN, CREA, AST, ALT, ALP, and TBIL of mice after intravenous 
injection with the charged IONPs (2 µg/g and 10 µg/g) for 24 h. (n = 3) 
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Figure 13. Histological analysis of balb/c mice after exposure of three charged IONPs (2 µg/g and 10 
µg/g) for 24 hr in six organs; kidney, liver, lung, heart, spleen, and brain. Toxicity level rated from 0 to 
5. (n = 3) 
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2.4 Conclusions 
 
We successfully developed the three differently charged IONPs for high colloidal stability and 
performed a systematic evaluation of cytotoxicity in the three human cell lines-A549, Huh-7, and SH-
SY5Y. Through RAFT polymerization and ligand exchange method, we prepared three differently 
charged IONPs with DMA as multiple anchoring groups, hydrophilic PEG polymer, negative carboxylic 
acid, and positive quaternary amine. All of the charged IONPs showed monodispersion with narrow 
size distribution in aqueous solution and high colloidal stability for up to three months in DIW and two 
days in RPMI 1640 and DMEM cell culture media without agglomeration. Depending on the 
concentration of IONPs, toxicity was assessed in vitro in three cell lines (lung, liver, and brain) by 
investigating cell viability test, morphology change. In MTT assay, all of the charged IONPs showed 
no significant toxicity in each cells up to the maximum concentration of 500 µg Fe/mL, and there was 
also no critical damage of cell morphology in all each cells. In vivo test, we performed hematological 
and histological analysis in mice and the results showed that the three differently charged IONPs are 
non-toxic and biocompatible materials. These results suggest that the charged IONPs with high stability 
and low toxicity in physiological conditions have potential for application at various bio-medical field. 
 
  
38 
 
III. Multidentate Catechol-Based Zwitterionic Ligand for Excellent Stability 
and Bio-Functionalization to Iron Oxide Nanoparticles 
 
3.1. Introduction 
 
IONPs have been studied in various bio-application such as MRI contrast agent,49 drug delivery,50 
and hyperthermia51 because they have unique properties such as superparamagnetism, low toxicity, and 
easy surface modification.52 High-quality IONPs synthesized by thermal decomposition method in hot 
surfactant solution are required for additional surface modification process to render the IONPs 
biocompatibility because initial IONPs have hydrophobic ligands. In general, surface of the IONPs 
should meet the following requirements for bio-application; i) high colloidal stability in wide pH ranges 
and saline solutions, ii) compact and uniform H.D, iii) reduced nonspecific binding with proteins of 
biological media, and iv) easy functionalization to biomolecules. 
For the various biomedical application, it is important to do surface engineering of IONP for the 
functionalization. There are two main reliable approaches for biocompatible and bio-functional surface 
of IONPs such as encapsulation and ligand exchange. Encapsulation can preserve the native ligands 
and maintain the physical properties, but it tends to increase the H.D of the final hydrophilic 
nanoparticles.53 Ligand exchange can replace the hydrophobic shell on IONPs with biocompatible 
ligands, which consist of anchoring groups, hydrophilic groups, and functional groups. Ligand can be 
composed of anchoring group for binding onto the surface of the IONPs, hydrophilic group for 
dispersity in water such as PEG and zwitters, and other functional groups for conjugation of bio-
molecules. Catechol has been used as anchoriong group for binding onto the IONPs because it exhibits 
strong affinity to metal oxide nanoparticles such as iron oxide, titanium oxide, alunium oxide.54 PEG 
has been well known for stealth materials as hydrophilic molecules because it has good water solubility, 
colloidal stability, and long-term circulation time in vivo. In addition, multidentate anchoring groups 
improve colloidal stability of the IONPs in biological media by enhancing the affinity of ligands with 
the surface of IONPs, while monodentate anchoring groups which have weak binding affinity with the 
IONPs surface. Therefore, multidentate catechol-based PEG ligand systems and have been studied for 
surface coating of IONPs for high stability and biocompatibility.55 However, previous PEG-based 
IONPs have had limitations such as increasing H.D of IONPs, and being unstable in acidic or high 
saline buffer resulting in aggregation. These limitations can prevent renal excretion and cause the 
accumulation in organs.56  
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Recently, several research groups have reported zwitterionic materials to overcome these limitations 
of PEG. Zwitterionic ligands containing both positive and negative charge groups in one molecule have 
zero net charge. They provide strong hydration that can capsulate the NPs and prevent aggregation and 
excellent resistance to nonspecific protein adsorption owing to their highly dense and zero net charge.57-
58 The IONPs coated with zwitterionic polymer with multiple anchoring groups have been little studied 
so far, as well as have been not applied to quntum dots,59-60 gold nanoparticles61 and silver nanoparticle62 
athough there have been studies about development of low-molecular weight zwitterionic coating 
materials including sulfobetaine,37 carboxybetaine,63 phosphorylcholine,64 and poly(acrylic) aicd.65 
In this study, we have developed a new multidentate catechol-based zwitterionic ligand (MCZ-ligand) 
system in order to increase the colloidal stability of IONPs. MCZ-ligand was synthesized by RAFT 
polymerization which offers the ability to control properties of polymer as desired by varying 
composition and ratio of monomers. Hydrophobic ligand of initally synthesized IONPs was replaced 
with the MCZ-ligand by simple coating method one step and the MCZ-ligand coated IONPs (MCZ-
IONPs) was well dispersed in water uniformly and compactly, and MCZ-IONPs showed excellent 
colloidal stability and was able to easily introduce bio-functional groups.  
  
40 
 
3.2 Materials and Experimental Section 
 
3.2.1 Materials. [3-(Methacryloylamino)propyl]dimethyl(3-sulfopropyl)ammonium hydroxide 
inner salt (ZMA), 2-Carboxyethyl acrylate, 2-Cyano-2-propyl benzodithioate, 4,4’-Azobis(4-
cyanovaleric acid), Bis(hexamethylene)triamine, N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC) were purchased from Sigma Aldrich. 2,2,2-Trifluoroethanol were purchased from 
Alfa-Aesar and N-Hydroxysulfosuccinimide sodium salt (sulfo-NHS) were purchased from TCI. 1X 
PBS, 1 M MES buffer were purchased from Biosesang. DMA and biotinylated methacrylate were 
synthesized as above procedures.  
3.2.2 Synthesis of OAc-IONPs. 12 nm sized OAc-IONPs were synthesized by using a previously 
described thermal decomposition method in the high boiling solvent.40 Synthesized OAc-IONPs were 
analyzed by TEM (JEOL, JEM-2100F). 
3.2.3 Synthesis of MCZ-Ligand. We synthesized MCZ-ligand by RAFT polymerization method. 
Polymer was composed of 20% DMA as anchoring groups and 80% ZMA as hydrophilic groups. First, 
DMA (0.2 mmol), 2-Cyano-2-propyl benzodithioate (0.05 mmol), 4,4’-Azobis(4-cyanovaleric acid) 
(0.05 mmol) were dissolved in 250 μL methanol, and ZMA (0.8 mmol) was dissolved in 750 μL 2,2,2-
Trifluoroethanol. Two solutions were mixed and transferred to 5 mL ampule. After 4 cycles of freeze-
pump-thaw, the ampule was sealed by using a torch under vacuo. The mixture was heated to 70°C and 
reacted for overnight. After reaction, the excess residues were washed with 2,2,2-Trifluoroethanol and 
acetone by centrifugation. We repeated this washing process three times and solvent was removed in 
vacuo to obtain the final polymer products. Synthesized polymers were confirmed by 1H NMR using 
AVANCE III HD (Bruker) instrument at 400 MHz using deuterium oxide solution. Molecular weight 
and molecular weight distribution were determined by GPC (Agilent). 
3.2.4 Surface Modification of OAc-IONPs via Ligand Exchange Method. OAc-IONPs (10 mg) 
were dissolved in 400 μL CHCl3, MCZ-ligand (30 mg) was dissolved in 200 μL 2, 2, 2-Trifluoroethanol. 
Two solutions were mixed in 10 m L vial and added 200 μL DIW. The vial was heat to 60°C and reacted 
for 12 h. After the reaction, the solution was precipitated in acetone by centrifugation (3 min, 3000 rpm) 
and the precipitates were dissolved in DIW. To remove the excess reagent, we used a centrifugal filter 
(MWCO 50 k) and washed out in DIW and repeated three times. Final MCZ-IONPs were stored in DIW.  
3.2.5 Stability Test of IONPs in Various pH Solutions and Saline Solutions. Different pH buffer 
solutions (pH 3, 5, 7, 9, 11) and various concentration of sodium chloride solution (0.1 M, 1 M, 2 M) 
were prepared and 12 nm MCZ-IONPs were added to each buffer solution. Final concentration of the 
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IONPs sample was 3 mM. The H.D of the IONPs was measured using a DLS (Malvern Zetasizer Nano-
ZS90) equipped with a detection angle fixed at 90˚ degrees and laser wavelength providing at 633 nm. 
3.2.6 Protein Adsorption Test. 0.05 μM MCZ-IONPs were mixed with various concentration bovine 
serum albumin (BSA) in 1X PBS. After incubation for 30 min, we measured H.D of IONPs by DLS. 
3.2.7 Synthesis of Amine Linked Biotinylated IONPs. First, we synthesized carboxylated 
zwitterionic ligand according to the same way as described above except for the addition 2-carboxyethyl 
acrylate. Next, OAc-IONPs were coated with the carboxylated zwitterionic ligand as according to 
described method above. For synthesis of amine functionalized IONPs, we used diamine linker; 
Bis(hexamethylene)triamine. In carboxylated zwitterionic coated IONPs solution (0.1 nmol), EDC (1 
μmol) and sulfo-NHS (0.5 μmol) were added and the mixtures were reacted in 10 mM MES buffer (pH 
6). After for 30 min, Bis(hexamethylene)triamine (1.2 μmol) was added the solution which was pH 8 
solution made by 0.5 M sodium carbonate buffer. Final volume of mixtures was 500 μL. Finally, amine 
linked biotinylated IONPs (AB-IONPs) were synthesized. Biotin (1 μmol) was dissolved in DMSO, 
and the biotin solution, EDC (1.2 μmol), and sulfo-NHS (0.6 μmol) were added the biotin solution. 
After 30 min, amine functionalized IONPs were mixed with the biotin solution, and the mixture was 
reacted for 12 h in sodium phosphate buffer solution (pH 8). After reaction, excess reagents were 
removed by centrifugal filter (MWCO 50 k) with three times. Final AB-IONPs were stored in DIW.  
3.2.8 Synthesis of Direct Biotinylated IONPs. For synthesis of direct biotinylated IONPs (DB-
IONPs), first biotinylated methacrylate were synthesized as previously report.37 After that, biotinylated 
zwitterionic polymer was synthesized by using DMA, ZMA, and biotinylated methacrylate. OAc-
IONPs were coated with the biotinylated zwitterionic polymers via same ligand exchange method as 
described above. Then, final DB-IONPs were obtained.  
3.2.9 Interaction Between Biotinylated IONPs and Streptavidin Solution. After synthesis of AB-
IONPs and DB-IONPs, the 0.01 μM biotinylated IONPs were incubated with various concentration of 
streptavidin solution dispersed in 1X PBS for 30 min at room temperature. After incubation, the H.D 
of IONPs solution was measured by DLS.   
3.2.10 Streptavidin Conjugation on IONPs. In carboxylated zwitterionic IONPs solution (0.1 
nmol), EDC (1 μmol) and sulfo-NHS (0.5 μmol) were added and reacted in 10 mM MES buffer (pH 6). 
After for 30 min, streptavidin solution dispersed in 1X PBS (0.5 nmol) was added the IONPs solution 
which was pH 8 solution made by 0.5 M sodium carbonate buffer. Final volume of mixtures was 1500 
μL, and the mixtures were reacted for 12 h in pH 8 buffer solution. After reaction, excess reagents were 
removed by spin-down repeated 3 times at 15000 rpm for 30 min with 1X PBS. The final streptavidin 
conjugated IONPs (SA-IONPs) were stored at 1X PBS.  
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3.2.11 Interaction Between SA-IONPs and Biotin-Coated Silicon Glass. For specific interaction 
of SA-IONPs with biotinylated silicon glass, we prepared both the (3-Aminopropyl)trimethoxysilane 
(APTMS) coated silicon glass as control group and biotinylated silicon glass. First, the oxygen plasma 
was treated on both side of silicone materials, and put the silicone materials into the APTMS solution 
(0.5 % of APTMS in acetonitrile, v/v) for 1 h at room temperature. After that, the materials were washed 
with acetonitrile and methanol, and dried via nitrogen blowing. For coupling of biotin on to the APTMS 
coated silicon glass, the APTMS coated glass was placed in a mixture of 10 mM biotin, 10 mM HATU 
and 20 mM DIPEA in N,N-Dimethylformamide for 2 h, and excess biotin was washed with N,N-
Dimethylformamide and methanol. After that, the glass was dried using nitrogen gas. SA-IONPs were 
treated on the APTMS coated silicon glass and biotin coated silicon glass, and the glass were analyzed 
by scanning electron microscope (SEM) and Energy-dispersive X-ray spectroscopy (EDX) analysis. 
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3.3 Result and Discussion 
 
3.3.1 Synthesis and Characterization of MCZ-Ligand  
MCZ-ligand was synthesized by RAFT polymerization. The chemical synthetic scheme of MCZ-
ligand are showed in Figure 14a. The MCZ-ligands were composed of followed by three groups; 
anchoring groups, hydrophilic groups, and functional groups. Sulfobetaine group of zwitterionic 
monomer was introduced for reduce nonspecific protein adsorption.56 2-Cyano-2-propyl benzodithioate 
and 4,4'-Azobis(4-cyanovaleric Acid) were used as RAFT agent and inhibition with ratio of 1:1. To 
optimize polymerization condition, we varied some parameters such as solvent, polymerization time. 
First, we optimized solvents condition by using N, N-Dimethylformamide, methanol, water, and 2,2,2-
Trifluoroethanol to solve the problem of precipitation during the polymerization due to the different 
solubility of two monomers. The polymer was synthesized uniformly without precipitation in the 
combination of methanol and 2,2,2-Trifluoroethanol (no data). Next, polymer was synthesized 
depending on time; 3 h, 9h, and 18 h. The molecular weight was increased depending on time although 
there was a little difference at 9 h and 18 h. Therefore, polymerization time was optimized to 12 h.  
A ratio of 20% DMA and 80% ZMA was reacted and the final product was analyzed by 1H NMR 
analysis (Figure 14b). The calculated ratio was 17% of DMA and 83% of ZMA in polymer and it was 
similar to what we intended. GPC analysis showed a single peak and uniform molecular weight of 
23,400 (PDI = 1.26).  
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Figure 14. Synthesis and characterization of MCZ-ligand. (a) Scheme of MCZ-ligand synthesis, and 
(b)
 1
H NMR analysis of MCZ-ligand in D2O. 
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3.3.2 Surface Modification of IONPs and Characterization  
 
Many previous reports processed two step for surface ligand exchange of IONPs because MCZ-
ligand has strong hydrophilic properties and it is very difficult to modify.66 The first step is transferring 
particles to relative hydrophilic organic solvent and the second step is transferring them to aqueous 
solution, which is complex and cumbersome. Therefore, we optimized ligand exchange method for one 
step method. Figure 15a shows scheme of ligand exchange. There are two system, one is one-phase 
system which uses chloroform, TFE, and water combination, and the other is two-phage system which 
uses hexane and water. The one-phase system was able to compactly and homogeneously modify, while 
the heterogeneous H.D of the MCZ-IONPs was shown in two-phase system. It is considered that the 
IONPs and the MCZ-ligand could not be collided and well separated in the hexane and water solutions 
because the MCZ-ligand is strong hydrophilic. In the one-phase system, the OAc-IONPs were modified 
to MCZ-IONPs uniformly and compactly, and OAc-IONPs dispersed in hexane were transferred to 
DIW (Figure 15b). The H.D of MCZ-IONPs was about 20 nm and a little increased compared to OAc-
IONPs (Figure 15c). The zeta-potential of MCZ-IONPs was about -20 mV. We presumed that weakly 
negatively charged zeta-potential could be caused by terminal sulfone group of MCZ-ligand (Figure 
15d). PEGylated IONPs were prepared as a control group for comparing MCZ-IONPs in next colloidal 
stability and nonspecific binding test. 
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Figure 15. Surface modification of OAc-IONPs. (a) Scheme of IONPs ligand exchange. (b) TEM image 
of OAc-IONPs dispersed in hexane and camera images of OAc-IONPs, MCZ-IONPs, and PEGylated 
IONPs dispersed in hexane or water. (c) H.D and (d) zeta-potential of MCZ-IONPs and PEGylated 
IONPs measured by DLS. 
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3.3.3 Colloidal Stability and Nonspecific Binding Test 
 
It is very important that hydrophilic IONPs should have colloidal stability in physiological condition 
because the unstable IONPs are likely to be agglomerated or precipitated due to interaction with 
biomolecule in protein rich biological media. Therefore, the colloidal stability of the MCZ-IONPs was 
investigated in wide pH ranges (pH 3, 5, 7, 9, 11, 13) and various concentration of saline solutions 
(NaCl 0.1 M, 1 M, 2 M) depending on time (1 hour, 1 day, 1 week, 1 month) by measuring H.D via 
DLS. The MCZ-IONPs were well dispersed in DIW, wide pH buffer solutions and various concentration 
saline solutions compared to PEGylated IONPs. 
In the pH data, the MCZ-IONPs were well dispersed in all pH condition, from pH three to pH eleven 
solution for one month, without significant increase of H.D (Figure 16a). However, the PEGylated 
IONPs were aggregated after the one week in pH 3 and after one month in all the pH ranges except for 
pH 9. In the sodium chloride data, the MCZ-IONPs were well dispersed in various concentration of 
sodium chloride, while H.D of PEGylated IONPs was slightly increased in all solutions after one month 
(Figure 16b). Surprisingly, the MCZ-IONPs were stable in all conditions after one year, while the 
PEGylated IONPs were unstable in all pH ranges and precipitated in 2 M NaCl after 1 year (Figure 17). 
We presupposed that the zwitterion could interact with water molecules to form a hydration layer via 
swelling of structure, it could encapsulate the IONPs in saline solutions and prevent agglomeration even 
in severe conditions.57 These results indicate that the MCZ-IONPs have excellent colloidal stability in 
harsh condition. 
Furthermore, protein adsorption of the IONPs was investigated. In biological environment, there are 
various biomolecules and the biomolecules can interact with the IONPs. After the interaction, protein 
corona can be formed and it can directly influence colloidal stability and behavior of the IONPs in cell 
and in vivo. To analyze nonspecific protein adsorption of the MCZ-IONPs and PEGylated IONPs, each 
IONPs was incubated with BSA proteins for 30 min in 1X PBS. As a result, the both MCZ-IONPs and 
PEGylated IONPs were maintained the initial H.D without a size increase or aggregation after 
incubation with BSA (Figure 18). Because the synthesized MCZ-IONPs are bipolar and negative 
charges induce charge repulsion, they have good dispersibility in water and superior stability in 
interaction with protein. Non-ionic PEG also maintained colloidal stability without adsorption because 
of its stealth characteristics. 
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Figure 16. Stability test of MCZ-IONPs and PEGylated IONPs. (a) IONPs dispersed in wide pH 
buffer ranges and (b) dispersed in various concentration saline solutions for 1 month. The H.D 
measured by DLS.  
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Figure 17. Stability test of MCZ-IONPs and PEGylated IONPs dispersed in wide pH buffer ranges and 
various concentration of saline solutions. (a) IONPs dispersed in pH buffers, and (b) dispersed in saline 
solutions for 1 year. The H.D measured by DLS. 
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Figure 18. Nonspecific binding test of MCZ-IONPs and PEGylated IONPs with BSA proteins. 
50 
 
3.3.4 Bio-Functionalization 
 
Bio-functionalization of IONPs is essential for application in various biomedical fields such as drug 
delivery carrier, targeting and therapeutic agent, MRI contrast agent, and imaging probe. For bio-
functionalization, ligands of the IONPs need functional groups such as carboxyl group, amine group, 
thiol group and so on. Generally IONPs are functionalized with useful bio-molecule via carbodiimide 
chemistry which forms amid bond. To investigate the potential of bio-functionalization of our 
synthesized MCZ-IONPs, biotin and streptavidin were selected as a small molecule and large molecule 
respectively because biotin and streptavidin have extremely high binding affinity each other. If biotin-
functionalized IONPs are mixed with a streptavidin solution at an appropriate concentration, the biotin-
functionalized IONPs will be agglomerated because of the interaction between biotin and streptavidin. 
Conversely, if SA-IONPs are mixed with a biotin solution, the same phenomenon occurs. In this study, 
biotin was conjugated on surface of the MCZ-IONPs in two different methods. One is using diamine 
linker (Figure 19a). First, carboxylated zwitterionic ligand was synthesized via RAFT polymerization 
and the OAc-IONPs were coated with the carboxylated zwitterionic ligand. Next, the carboxylated 
zwitterionic IONPs were functionalized with amine groups by using diamine linker. After that, biotin 
was conjugated with amine group functionalized IONPs. Then, AB-IONPs were synthesized. The other 
method is direct functionalization biotin onto the IONPs (Figure 19b). First, biotinylated zwitterionic 
polymer was synthesized and the OAc-IONPs were coated with the biotinylated zwitterionic polymers. 
Then, DB-IONPs were synthesized. The former has the great advantage that we can utilize the carboxyl 
group or amine group of IONPs to functionalize various molecule such as drug or targeting moieties as 
we desired and the latter is possible of simple and reliable biotin functionalization. In the synthesis of 
ligand, we easily the controlled of the composition of polymers. The ratio of carboxyl group was 
controlled and it was analyzed by 1H NMR (Figure 20). In NMR data, the ratio of carboxyl group was 
increased as more as added in polymers.  
Biotinylated IONPs were aggregated in streptavidin solution because of the strong interaction 
(Figure 21a). Therefore, we confirmed interaction between biotin on the IONPs and streptavidin 
solution after synthesis of AB-IONPs and DB-IONPs. The H.D change of the AB-IONPs and DB-
IONPs was observed after incubation with streptavidin solution, respectively. After adding the AB-
IONPs to streptavidin solution, the H.D of IONPs was changed. The AB-IONPs were decreased and at 
the same time and the aggregated molecules were observed because of biotin-streptavidin interaction 
(Figure 21b). In case of DB-IONPs, same trend of biotin-streptavidin interaction was observed. These 
results indicate that both AB-IONPs and BD-IONPs were successfully functionalized with biotin 
molecules. 
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To synthesize of SA-IONPs, carbodiimide chemistry was introduced for forming amide bond between 
carboxyl groups of carboxylated zwitterionic IONPs and amine groups of streptavidin. The SA-IONPs 
were analyzed by SEM and EDX analysis. Two types silicon glass were prepared, one was treated only 
APTMS and the other was coated with biotin. Figure 22a shows scheme of interaction between SA-
IONPs and silicon glass. After treatment of the SA-IONPs on each silicon glass, streptavidin-biotin 
interaction was observed by SEM image (Figure 22b). Compared to control groups coated with only 
APTMS, the SA-IONPs were more observed on the biotin coated silicon glass. In Figure 22c, an 
increase of iron and carbon element derived from SA-IONPs was confirmed by EDX analysis. The 
number and area of the SA-IONPs binding on glass were calculated as shown in Figure 22d and they 
were larger about 20 times than that of on the APTMS coated glass. These results indicate that the 
MCZ-IONPs were successfully functionalized with streptavidin. This means that our synthesized MCZ-
IONPs have a potential of bio-functionalization with various macromolecules. 
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Figure 19. Synthesis of biotinylated IONPs. (a) AD-IONPs and (b) DB-IONPs. 
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Figure 20. Synthesis of carboxylated zwitterionic ligand and control of the ratio of carboxyl group in 
polymers. The polymer was characterized by 1H NMR analysis. 
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Figure 21. Biotin-streptavidin interaction. (a) Scheme of interaction between biotinylated IONPs and 
streptavidin in solution. (b) The H.D change of AB-IONPs and DB-IONPs after interaction with 
streptavidin. 
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Figure 22. (a) Scheme of interaction between APTMS coated silicon glass or (b) biotin coated silicon 
glass and SA-IONPs. (b) SEM images, (c) EDX analysis of APTMS coated silicon glass treated SA-
IONPs and biotin coated silicon glass treated SA-IONPs, and (d) summary table of IONPs number and 
area interaction with silicon glass. 
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3.4 Conclusions 
 
In this study, we developed the MCZ-ligand by RAFT polymerization for excellent colloidal stability 
and easy bio-functionalization of IONPs. The MCZ-IONPs showed excellent colloidal stability at wide 
pH ranges and various concentrations of sodium chloride solution for 1 month and it is superior stable 
than PEGylated IONPs. In addition, the MCZ-IONPs showed the least nonspecific adsorption with BSA 
proteins. By introducing the multidentate catechol-based anchoring group, we could enhance binding 
affinity to IONPs. The IONPs showed good colloidal stability owing to the advantages of zwitterion. 
Furthermore, the MCZ-IONPs had the potential of bio-functionalization with useful bio-molecules such 
as biotin and streptavidin. We performed bio-functionalization of IONPs with biotin or streptavidin via 
strong interaction between biotin and streptavidin. We could simply synthesize functionalized ligands 
which have carboxyl groups, or amine groups by RAFT polymerization and conjugated streptavidin 
and biotin on to the IONPs. These result indicate that our MCZ-ligand provides highly excellent 
colloidal stability to the IONPs and this promising ligand system of IONPs can extend its ability of bio-
functionalization for biomedical application.  
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